Compare Alcon AG (ALC) vs Philip Morris International Inc. (PM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Philip Morris International Inc. — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Philip Morris International Inc. trades at $187.41 (market cap $287.96B). The key difference: Philip Morris International Inc. is far larger — about 8.8× Alcon AG's market cap, and Philip Morris International Inc. pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| ALC | PM | |
|---|---|---|
Market Cap | $32.69B | $287.96B |
Sector | Health | Consumer Staples |
52-Week High | $92.22 | $191.86 |
52-Week Low | $62.02 | $144.33 |
Enterprise Value | $36.28B | $334.46B |
Dividend Yield | 0.54% | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $187.07, up 1.25% on the day, near its pivot point of $187 with strong analyst support. Recent Q1 2026 EPS beat expectations at $1.96 versus $1.86, though Q4 2025 missed. Revenue grew to $40.65B in 2025 with a robust net margin of 26.74%, while technical indicators show a bullish moving average signal but RSI_6 at 73.87 suggests overbought conditions. The company announced a $1.47 dividend payable July 20, 2026, and faces headwinds from a $500 million impairment charge and EU illicit market growth.
Outlook remains cautiously positive with a consensus price target of $194.25, offering ~4% upside. Strengths include high profitability and brand value, but risks involve cost pressures, regulatory challenges, and debt levels. The stock presents a hold-to-buy opportunity for dividend-focused investors, pending Q2 2026 earnings results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
